A two-phase pathogenesis of graft-versus-host disease in mice
- 1 January 2002
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 29 (2) , 151-158
- https://doi.org/10.1038/sj.bmt.1703328
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 16 references indexed in Scilit:
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- Relevance of tumor necrosis factor to graft-versus-host disease after small bowel transplantationTransplant International, 1993
- Increased risk of relapse in patients with chronic myelogenous leukemia given T‐cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft‐versus‐host diseaseEuropean Journal of Haematology, 1993
- Differential cytokine expression in acute and chronic murine graft‐versus‐host‐diseaseEuropean Journal of Immunology, 1993
- In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment.The Journal of Experimental Medicine, 1990
- Interleukin-2: Inception, Impact, and ImplicationsScience, 1988
- Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences.The Journal of Experimental Medicine, 1986
- Persistence of host Langerhans cells following allogeneic bone marrow transplantation: possible relationship with acute graft‐versus‐host diseaseBritish Journal of Haematology, 1985
- Selection of cytotoxic T-cell precursors specific for minor histocompatibility determinants. I. Negative selection across H-2 barriers induced with disrupted cells but not with glutaraldehyde-treated cells: evidence for antigen processing.The Journal of Experimental Medicine, 1980
- Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.The Journal of Experimental Medicine, 1978